For the Quarter Ending March 2026
听
Naproxen Prices in听North America
- In USA, the Naproxen Price Index fell by 0.25% quarter-over-quarter, import-alert tightened spot availability somewhat.
- The average Naproxen price for the quarter was approximately USD 28886.33/MT reported by CFR Los Angeles market intelligence.
- Naproxen Spot Price remained narrowly ranged as import availability stabilized following Indian plant compliance actions.
- Naproxen Price Forecast indicates modest volatility ahead driven by cautious importer buying and steady prescription demand.
- Naproxen Production Cost Trend remained stable as Acetic Anhydride feedstock prices and freight showed limited movement.
- Naproxen Demand Outlook shows seasonal OTC uplift while prescription volumes stayed unchanged, supporting consistent offtake levels.
- Naproxen Price Index signals marginal upward bias as sellers maintained offers amid cautious buyer procurement strategies.
- Inventories at US distributors tightened slightly but allowed routine production continuity, limiting sharp Naproxen price movements.
Why did the price of Naproxen change in March 2026 in North America?
- Import offers held firm after freight surcharges; limited new low-priced cargoes marginally tightened landed-cost competitiveness.
- Feedstock Acetic Anhydride costs and war-related shipping risk premiums pressured exporter offers into Los Angeles.
- Winter restocking supported demand while buyers remained cautious, delaying spot purchases and keeping market balanced.
听
Naproxen Prices in听APAC
- In China, the Naproxen Price Index fell by 0.23% quarter-over-quarter, reflecting feedstock and margin pressures.
- The average Naproxen price for the quarter was approximately USD 28786.67/MT, based on FOB Shanghai.
- Naproxen Spot Price showed thin offers as export warehouse inventories tightened, supporting Naproxen Price Index.
- Naproxen Production Cost Trend worsened as Acetic Anhydride jumped sharply, compressing netbacks for Chinese exporters.
- Naproxen Demand Outlook remains steady with US and German restocking offsetting muted domestic OTC purchases.
- Naproxen Price Forecast anticipates volatility as shipping risk premia and energy costs influence FOB negotiations.
- Producers maintained planned campaigns; disciplined allocations kept export yields balanced, reflected in Naproxen Price Index stability.
- Tight export warehouse stocks and port operations sustained seller pricing power across FOB markets this quarter.
Why did the price of Naproxen change in March 2026 in APAC?
- Feedstock spike: Acetic Anhydride surged markedly in March, elevating Naproxen production costs and pressuring margins.
- Export dynamics: steady US and German enquiries absorbed tighter supply, allowing cost pass-through for FOB offers.
- Logistics and inspections: environmental audits temporarily reduced operating intensity, ports remained uncongested and shipments flowed.
听
Naproxen Prices in听Europe
- In Germany, the Naproxen Price Index fell by 0.25% quarter-over-quarter, reflecting stable supply and demand.
- The average Naproxen price for the quarter was approximately USD 28886.67/MT delivered CFR Hamburg suppliers.
- Naproxen Spot Price movements were limited as routine Indian and Spanish shipments maintained consistent availability.
- Naproxen Price Forecast signals mild near-term oscillation as importers balance replenishment with cautious procurement planning.
- Naproxen Production Cost Trend stayed subdued; exporters absorbed energy cost increases, limiting landed price pressure.
- Naproxen Demand Outlook remains steady, driven by pharmacy replenishment and manufacturer requirements supporting routine production.
- Port inventories at four-week cover supported Naproxen Price Index, limiting impact from freight and utility.
- Major Indian API plants completed maintenance, increasing export volumes and preventing supply-driven Naproxen price spikes.
- Calm logistics and ample availability preserved narrow spreads, limiting pressure on the Naproxen Price Index.
Why did the price of Naproxen change in March 2026 in Europe?
- Limited upstream disruptions and steady Indian exports maintained supply, keeping German spot assessments largely unchanged.
- Slightly firmer offers reflected higher compliance and utility costs in exporters, supporting landed CFR prices.
- Smooth Hamburg port operations and stable freight prevented logistics-driven premium, allowing buyers to delay replenishment.
For the Quarter Ending December 2025
North America
- In USA, the Naproxen Price Index fell by 2.8% quarter-over-quarter, reflecting ample inbound Asian supply.
- The average Naproxen price for the quarter was approximately USD 42236.67/MT based on import volumes
- Naproxen Spot Price eased in December; Price Index reflected importers taking lower Asian export offers
- Naproxen Price Forecast indicates mild recovery early 2026 driven by seasonal procurement and tighter availability
- Naproxen Production Cost Trend neutral as feedstock and utility costs stayed stable for domestic producers
- Naproxen Demand Outlook shows steady hospital and retail uptake but seasonal OTC consumption softened post-promotions
- Naproxen Price Index is sensitive to inventory levels and export cadence from India and China
- Major supplier rates remained steady while Los Angeles port operations supported arrivals and contained volatility
Why did the price of Naproxen change in December 2025 in North America?
- Ample Asian shipments increased port inventories, reducing urgency for spot purchases and pressuring landed prices
- Seasonal post-promotion retail softening lowered OTC demand, moderating procurement and weakening short-term market bids significantly
- Stable feedstock and utility costs left production cost pressures muted, exporters reduced dollar-denominated quotes accordingly
APAC
- In China, the Naproxen Price Index fell by 1.19% quarter-over-quarter, reflecting subdued buying and inventories.
- The average Naproxen price for the quarter was approximately USD 28853.33/MT, per trade-statistics reports data.
- Naproxen Spot Price softened in December after restocking ended, increasing availability and lowering Price Index.
- Naproxen Price Forecast indicates modest near-term weakness absent stronger feedstock pressure or hospital tender recovery.
- Naproxen Production Cost Trend showed minor feedstock increases yet remained insufficient to sustain higher offers.
- Naproxen Demand Outlook points to seasonal uptick but hospital budget exhaustion kept immediate offtake muted.
- Elevated inventories and quieter export enquiries pressured the Price Index while plants maintained operating-rates.
- Producers' stable output and functional logistics limited volatility, constraining upside pressure on Naproxen Spot Price.
Why did the price of Naproxen change in December 2025 in APAC?
- Comfortable production and higher inventories reduced scarcity, easing upward pressure on Naproxen prices in December.
- Post-promotion lull and exhausted hospital budgets curtailed demand, weakening transactional volumes and pressuring Price Index.
- Acetic-anhydride rose but cost increases insufficient to counter weaker demand and subdued market-dynamics.
Europe
- In Germany, the Naproxen Price Index fell by 2.93% quarter-over-quarter, reflecting larger-than-normal import arrivals and weakened spot buying.
- The average Naproxen price for the quarter was approximately USD 42230.00/MT, based on reported trade totals.
- Inventory builds pressured the Naproxen Spot Price and expanded merchant stocks across Hamburg and Bremen free zones.
- Lower freight and stable feedstock costs influenced the Naproxen Production Cost Trend, supporting price competitiveness versus local manufacturers.
- Winter analgesic demand provided modest support; the Naproxen Demand Outlook remains seasonal, while the Naproxen Price Index softened.
- Market participants expect limited near-term upside; the Naproxen Price Forecast points to further modest downside absent supply disruption.
- Indian debottlenecking and steady Spanish allocations increased arrivals, pressuring German import-dependent supply balances and offers.
- Distributors trimmed purchases ahead of reimbursement resets, prioritizing inventory drawdown and reducing Naproxen spot buying momentum.
Why did the price of Naproxen change in December 2025 in Europe?
- Surge in Indian and Spanish shipments swelled merchant inventories, undermining local spot prices and seller leverage.
- German wholesalers curtailed end-year procurement ahead of reimbursement resets, reducing spot demand despite seasonal analgesic offtake.
- Lower Asia-Europe freight and stable feedstock costs cut landed costs, enabling deeper discounts and heightening downward pressure.
For the Quarter Ending September 2025
North America
- In USA, the Naproxen Price Index rose by 1.62% quarter-over-quarter, reflecting modest import demand recovery.
- The average Naproxen price for the quarter was approximately USD 43497.67/MT amid steady pharmaceutical procurement.
- Naproxen Spot Price softened as exporters offered discounts, lowering the Naproxen Price Index urgency slightly.
- Naproxen Demand Outlook remains cautious with measured restocking ahead of winter, supporting purchases and stability.
- Naproxen Production Cost Trend was stable as propionic acid availability kept manufacturing costs contained abroad.
- Naproxen Price Forecast suggests upward pressure into Q4 as restocking supports the Naproxen Price Index.
- High inventories curtailed buying, improving export demand with efficient logistics provided intermittent support to prices.
- Major producers operated smoothly with steady output maintaining supply stability, limiting Naproxen Spot Price volatility.
Why did the price of Naproxen change in September 2025 in North America?
- Subdued domestic demand and high stocks reduced urgency, causing exporters to lower offers and prices.
- Stable propionic acid costs lowered production expenses, enabling exporters to discount Naproxen Spot Price offers.
- Efficient logistics smooth port operations meant price changes were driven by demand, exporter offer adjustments.
APAC
- In China, the Naproxen Price Index rose by 1.72% quarter-over-quarter, reflecting demand recovery in Q3 2025.
- The average Naproxen price for the quarter was approximately USD 41230.00/MT as reported by Ex-Works quotations.
- Naproxen Spot Price eased after June correction, sellers adjusted offers to stimulate cautious procurement recovery.
- Naproxen Price Forecast signals moderate firming into Q4 as distributors rebuild stocks ahead of seasonal demand.
- Naproxen Production Cost Trend remained stable due to steady propionic acid availability and intermediate costs.
- Naproxen Demand Outlook shows steady pharmaceutical offtake from NSAID formulations, lacking aggressive restocking impulse presently.
- High inventories pressured the Naproxen Price Index as exporters and buyers paused purchases to manage stock.
- Export enquiries fluctuated, with buyers adopting tactical sourcing, moderating near-term Naproxen spot demand recovery slightly.
Why did the price of Naproxen change in September 2025 in APAC?
- Suppliers aggressively corrected offers after earlier hike, inducing downward pressure on spot and contract prices.
- Stable feedstock costs and uninterrupted production removed cost-push drivers, allowing oversupply to determine price movement.
- Demand remained cautious with high inventories and muted export enquiries, reducing urgency for replenishment across channels.
Europe
- In Germany, the Naproxen Price Index rose by 1.74% quarter-over-quarter, reflecting modest importer restocking activity.
- The average Naproxen price for the quarter was approximately USD 43503.67/MT, reflecting subdued procurement patterns.
- Naproxen Spot Price softened mid-quarter as exporters cut offers amid weaker European buying interest overall.
- Naproxen Price Forecast signals modest upward bias into autumn driven by seasonal NSAID restocking volumes.
- Naproxen Production Cost Trend remained benign as propionic acid stayed inexpensive, limiting manufacturer cost pressures.
- Naproxen Demand Outlook improved gradually with pharmaceutical and OTC restocking ahead of colder-season treatment cycles.
- Naproxen Price Index volatility was muted by smooth logistics, steady supply and inventory-driven buyer behavior.
- Importers maintained measured purchases, balanced inventories, and awaited clearer signals influencing Naproxen Price Forecast direction.
Why did the price of Naproxen change in September 2025 in Europe?
- Exporters lowered offers after May rallies, increasing downward pressure on landed prices, cooling buyer interest.
- Weak summer demand and elevated downstream inventories reduced buying urgency across pharmaceutical and OTC sectors.
- Stable feedstock costs and smooth logistics reduced cost pressures, leaving demand dynamics the price driver.
For the Quarter Ending June 2025
North America
- The Naproxen Spot Price Index in North America fell sharply in June 2025 by -5.39% and settled at USD 42,688/MT CFR Los Angeles. This decline followed a steep speculative price rise in May that was not supported by actual procurement momentum.
- Why did the price change in July 2025?
The Naproxen Spot Price in the U.S. has declined in early July due to continued subdued demand and sustained inventory overhang. The buyers were hesitant following the sharp June corrections with the Naproxen Price Forecast signalling further weakness unless fresh demand triggers emerge. The suppliers have adjusted offers lower to preserve market share in a stagnant procurement environment.
- After peaking in May (up 11.13%), prices in June collapsed due to buyer resistance and overextension by suppliers. The Q2 price trajectory moved from stability in April (+1.10%) to aggressive hikes in May, followed by correction in June which reflected a classic speculative cycle.
- The Naproxen Production Cost Trend remained flat through Q2. Steady feedstock supply鈥攑articularly Propionic Acid鈥攅nsured smooth manufacturing at origin countries, with no operational bottlenecks or raw material constraints reported.
- The Naproxen Demand Outlook in Q2 was steady but muted. U.S. pharmaceutical and OTC buyers adopted cautious restocking strategies. Without promotional drivers or seasonal uptick, offtake remained aligned with baseline needs and discouraged speculative buying.
- Importers maintained well-balanced inventories and avoided excess procurement in June. The previous month鈥檚 high prices led many to delay fresh intakes, reinforcing downward price pressure and delaying any firming trend in the Naproxen Price Forecast.
- Inland transport and port operations at Los Angeles remained smooth throughout Q2. No logistics disruptions influenced the market, and pricing fluctuations were entirely driven by speculative corrections and export quotation trends.
- Chinese and Indian exporters initially pushed aggressive offers in May to capitalize on firm global demand, but softened quotes by June due to global buyer resistance. This behaviour created price volatility in the U.S. import market.
- The Naproxen Price Forecast for Q3 suggests moderate downside risk unless pharmaceutical demand improves or stock levels normalize. Buyers are likely to remain defensive until clear pricing cues or seasonal demand emerge.
Asia Pacific
- The Naproxen Spot Price Index in Shanghai declined by 5.56% in June, reaching USD 40,375/MT EXW. This correction followed the unsustainable 11.11% increase in May, which met buyer resistance both domestically and internationally.
- Why did the price change in July 2025?
In early July, Naproxen Spot Prices in China and broader APAC slipped marginally again. Buyers were still reeling from May鈥檚 spike and approached July with caution. With subdued offtake and steady production, suppliers maintained competitive offers. The Naproxen Price Forecast points to continued softness unless demand improves.
- Q2 began with a modest +0.85% price increase in April, turned sharply bullish in May due to strong overseas demand, and dropped steeply in June amid pricing fatigue. The region tracked the classic rise-correction pattern seen globally.
- The Naproxen Production Cost Trend remained neutral. Feedstock Propionic Acid was continuously available, and Chinese producers maintained stable output across Q2. No operational or regulatory disruptions were reported.
- The Naproxen Demand Outlook stayed flat in June. Pharmaceutical buyers procured only as needed. OTC brands and hospital channels exhibited no urgency due to stable inventory positions and the absence of health emergencies.
- Suppliers and distributors refrained from restocking aggressively in June. Inventories were managed cautiously amid price volatility. Most players opted for a wait-and-watch approach, further weighing on demand and prices.
- Logistics within China and toward regional trade partners remained efficient. No inland congestion or policy hurdles impacted material movement. Hence, price declines stemmed from strategic price adjustments, not logistical disruptions.
- May鈥檚 bullish sentiment was supplier-led as exporters recalibrated long-static prices upward. However, as buyer pushback mounted in June, exporters softened their quotations, leading to immediate Naproxen Spot Price corrections.
- The Naproxen Price Forecast for Q3 APAC points to continued softness barring a medical sector upturn. Buyers will likely proceed cautiously until Q4 unless triggered by public health events or aggressive promotional procurement.
Europe
- The Price Index for Naproxen CFR Hamburg dropped by -5.47% in June, reaching USD 42,610/MT, reversing the previous 11.06% gain seen in May. This mirrored global price normalization and reflected German market conservatism.
- Why did the price change in July 2025?
In early July, Naproxen Spot Prices in Europe dropped further in response to a global downward correction. With German buyers still absorbing high-cost May stocks and demand stagnating, suppliers cut export offers. The Naproxen Price Forecast for Europe remains bearish amid low OTC and prescription activity.
- Q2 saw an initial modest price rise in April (+1.11%), followed by an aggressive May surge, then a sharp June correction. Europe mirrored the global speculative rally and subsequent buyer pushback seen across key import markets.
- The Naproxen Production Cost Trend was stable throughout Q2. Exporters operated with steady feedstock flows (Propionic Acid), while no upstream disruptions or capacity constraints emerged at origin sites in Asia.
- The Naproxen Demand Outlook in Europe remained cautious. The pharmaceutical sector maintained routine orders, but no seasonal or promotional uplift occurred. Public health stability and full stocks meant no trigger for bulk purchases.
- German importers ran moderately balanced inventories, having procured heavily in May. The correction in June discouraged further buying. This hedging behavior shaped overall market inertia and reinforced softening sentiment.
- Port Hamburg and inland German transport networks remained congestion-free. The price movement was entirely influenced by external quotation strategies, with European distributors leveraging stable logistics to defer procurement amid falling prices.
- With global offers softening post-May, exporters were forced to reduce prices to sustain volume placements. Germany, reliant on imports, saw these adjustments directly impact the Naproxen Spot Price trajectory.
- The Naproxen Price Forecast for Q3 remains bearish unless demand picks up or inventory positions normalize. Distributors are expected to continue measured purchasing unless unexpected pharmaceutical trends shift fundamentals.
